6 hedge funds and family offices disclose a CRH position in their latest SEC 13F filing — combined $592.0M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Egerton Capital | Egerton Capital (UK) LLP | 2,261,060 | $282.2M | 3.07% | 2025-12-31 |
| 2 | Daniel Loeb | Third Point LLC | 2,195,000 | $234.9M | 5.02% | 2026-06-30 |
| 3 | Stanley Druckenmiller | Duquesne Family Office LLC | 553,555 | $59.2M | 1.14% | 2026-06-30 |
| 4 | George Soros | Soros Fund Management LLC | 123,942 | $13.3M | 0.16% | 2026-06-30 |
| 5 | Ray Dalio | Bridgewater Associates LP | 22,525 | $2.4M | 0.01% | 2026-06-30 |
| 6 | Christopher Bloomstran | Semper Augustus Investments Group LLC | 267 | $33K | 0.01% | 2025-12-31 |
As of the latest 13F window, 6 tracked superinvestors hold CRH. The largest disclosed position is Egerton Capital at $282.2M (3.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying CRH, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
6 hedge funds and family offices disclose a CRH position in their latest SEC 13F filing — combined $592.0M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Egerton Capital | Egerton Capital (UK) LLP | 2,261,060 | $282.2M | 3.07% | 2025-12-31 |
| 2 | Daniel Loeb | Third Point LLC | 2,195,000 | $234.9M | 5.02% | 2026-06-30 |
| 3 | Stanley Druckenmiller | Duquesne Family Office LLC | 553,555 | $59.2M | 1.14% | 2026-06-30 |
| 4 | George Soros | Soros Fund Management LLC | 123,942 | $13.3M | 0.16% | 2026-06-30 |
| 5 | Ray Dalio | Bridgewater Associates LP | 22,525 | $2.4M | 0.01% | 2026-06-30 |
| 6 | Christopher Bloomstran | Semper Augustus Investments Group LLC | 267 | $33K | 0.01% | 2025-12-31 |
As of the latest 13F window, 6 tracked superinvestors hold CRH. The largest disclosed position is Egerton Capital at $282.2M (3.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying CRH, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
